The National Cancer Institute (NCI) offers this grant to support the advanced development and technical validation of emerging molecular and cellular analysis technologies for cancer research. This grant targets technologies that have moved beyond pilot development, showing promise but lacking significant evaluation in their intended use. The objective is to accelerate research across various cancer domains, including biology, treatment, diagnosis, prevention, control, epidemiology, and health disparities. Applicants must demonstrate proof-of-principle with supporting preliminary data. Projects should propose novel molecular analysis technologies with potential for broad impact in cancer research. Applications focusing on established technologies, where the novelty lies only in the biological question, will not be considered.
Opportunity ID: 206214
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-13-002 |
| Funding Opportunity Title: | Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 10 |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 09, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 20, 2013 |
| Current Closing Date for Applications: | Sep 20, 2013 |
| Archive Date: | Oct 21, 2013 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses City or township governments State governments Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education County governments Native American tribal governments (Federally recognized) For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing research projects on the advanced development of emerging molecular and cellular analysis technologies and technical/analytical validation in an appropriate cancer-relevant biological system. An emerging technology is defined as one that has passed the pilot developmental stage and shows promise, but has not yet been significantly evaluated within the context of its intended use. If successful, these technologies would accelerate research in cancer biology, treatment, diagnosis, prevention, control, epidemiology, and/or cancer health disparities. This FOA solicits projects where proof-of-principle of the proposed technology or methodology has been established and supportive preliminary data are available. Projects proposed to this FOA should reflect the potential to produce a molecular analysis technology with a major impact in a broad area of cancer-relevant research. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued will be considered non-responsive and will not be reviewed. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-002.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00151432 | Jan 20, 2013 | Sep 20, 2013 | View |
Package 1
Mandatory forms
206214 RR_SF424_1_2-1.2.pdf
206214 PerformanceSite_1_4-1.4.pdf
206214 RR_OtherProjectInfo_1_3-1.3.pdf
206214 RR_KeyPersonExpanded_1_2-1.2.pdf
206214 PHS398_CoverPageSupplement_1_4-1.4.pdf
206214 PHS398_ResearchPlan_1_3-1.3.pdf
206214 PHS398_Checklist_1_3-1.3.pdf
Optional forms
206214 RR_SubawardBudget30-1.2.pdf
206214 PHS398_ModularBudget_1_2-1.2.pdf
206214 RR_Budget-1.1.pdf
206214 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
